These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 8356621)
21. Racial differences in incidence, outcome, and quality of life for African-Americans on hemodialysis. Owen WF Blood Purif; 1996; 14(4):278-85. PubMed ID: 8873953 [TBL] [Abstract][Full Text] [Related]
22. Risk factors for end-stage renal disease among minorities. Ferguson R; Morrissey E Transplant Proc; 1993 Aug; 25(4):2415-20. PubMed ID: 8356618 [TBL] [Abstract][Full Text] [Related]
23. Excess incidence of treatment of end-stage renal disease in Mexican Americans. Pugh JA; Stern MP; Haffner SM; Eifler CW; Zapata M Am J Epidemiol; 1988 Jan; 127(1):135-44. PubMed ID: 3276155 [TBL] [Abstract][Full Text] [Related]
24. Race/ethnicity, age, and risk of hospital admission and length of stay during the first year of maintenance hemodialysis. Yan G; Norris KC; Greene T; Yu AJ; Ma JZ; Yu W; Cheung AK Clin J Am Soc Nephrol; 2014 Aug; 9(8):1402-9. PubMed ID: 24948142 [TBL] [Abstract][Full Text] [Related]
25. Racial/ethnic disparities among Asian Americans in inpatient acute myocardial infarction mortality in the United States. Kim EJ; Kressin NR; Paasche-Orlow MK; Lopez L; Rosen JE; Lin M; Hanchate AD BMC Health Serv Res; 2018 May; 18(1):370. PubMed ID: 29769083 [TBL] [Abstract][Full Text] [Related]
26. Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study. Malhotra R; Cavanaugh KL; Blot WJ; Ikizler TA; Lipworth L; Kabagambe EK Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1079-1087. PubMed ID: 27562875 [TBL] [Abstract][Full Text] [Related]
27. Diabetes-related end-stage renal disease in Missouri: trends and variations by age and race. Urriola-Acheson A; Sharp DJ; Kruse KH; Austin DE; Weaver A; Brownson RC Mo Med; 1994 Jun; 91(6):287-90. PubMed ID: 8052218 [TBL] [Abstract][Full Text] [Related]
28. Racial differences in the prevalence of atrial fibrillation among males. Borzecki AM; Bridgers DK; Liebschutz JM; Kader B; Kazis LE; Berlowitz DR J Natl Med Assoc; 2008 Feb; 100(2):237-45. PubMed ID: 18300541 [TBL] [Abstract][Full Text] [Related]
29. Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system. Derose SF; Rutkowski MP; Crooks PW; Shi JM; Wang JQ; Kalantar-Zadeh K; Kovesdy CP; Levin NW; Jacobsen SJ Am J Kidney Dis; 2013 Aug; 62(2):236-44. PubMed ID: 23499049 [TBL] [Abstract][Full Text] [Related]
30. Albuminuria Testing by Race and Ethnicity among Patients with Hypertension with and without Diabetes. Lee J; Chu C; Guzman D; Fontil V; Velasquez A; Powe NR; Tuot DS Am J Nephrol; 2019; 50(1):48-54. PubMed ID: 31167180 [TBL] [Abstract][Full Text] [Related]
32. Incidence of end-stage renal disease among persons with diabetes--United States, 1990-2002. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(43):1097-100. PubMed ID: 16267496 [TBL] [Abstract][Full Text] [Related]
33. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. Li S; McAlpine DD; Liu J; Li S; Collins AJ Adv Ren Replace Ther; 2004 Jan; 11(1):5-13. PubMed ID: 14730534 [TBL] [Abstract][Full Text] [Related]
34. Trends in the incidence of treated end-stage renal disease secondary to diabetic nephropathy: 1975-1984. Kappel DF; Van Tuinen M Am J Kidney Dis; 1986 Oct; 8(4):234-8. PubMed ID: 3766529 [TBL] [Abstract][Full Text] [Related]
35. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Young BA; Maynard C; Boyko EJ Diabetes Care; 2003 Aug; 26(8):2392-9. PubMed ID: 12882868 [TBL] [Abstract][Full Text] [Related]
36. Ethnic disparities in diabetic complications in an insured population. Karter AJ; Ferrara A; Liu JY; Moffet HH; Ackerson LM; Selby JV JAMA; 2002 May; 287(19):2519-27. PubMed ID: 12020332 [TBL] [Abstract][Full Text] [Related]
37. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. Hsu CY; Lin F; Vittinghoff E; Shlipak MG J Am Soc Nephrol; 2003 Nov; 14(11):2902-7. PubMed ID: 14569100 [TBL] [Abstract][Full Text] [Related]
38. Diabetes mellitus and hypertension: key risk factors for kidney disease. Lea JP; Nicholas SB J Natl Med Assoc; 2002 Aug; 94(8 Suppl):7S-15S. PubMed ID: 12152917 [TBL] [Abstract][Full Text] [Related]
39. Variations in outcomes of hemodialysis vascular access by race/ethnicity in the elderly. Woo K; Gascue L; Goldman DP; Romley JA J Vasc Surg; 2017 Mar; 65(3):783-792.e4. PubMed ID: 28027805 [TBL] [Abstract][Full Text] [Related]
40. Incidence of treatment for end-stage renal disease attributed to diabetes mellitus, by race/ethnicity--Colorado, 1982-1989. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1992 Nov; 41(44):845-8. PubMed ID: 1435671 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]